NDC 59572-720

Inrebic

Fedratinib Hydrochloride

Inrebic is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Celgene Corporation. The primary component is Fedratinib Hydrochloride.

• Product ID: 59572-720_01379c31-1a97-41d0-b5a3-4c0ced421ff1
• NDC: 59572-720
• Product Type: Human Prescription Drug
• Proprietary Name: Inrebic
• Generic Name: Fedratinib Hydrochloride
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2019-08-16
• Marketing Category: NDA / NDA
• Application Number: NDA212327
• Labeler Name: Celgene Corporation
• Substance Name: FEDRATINIB HYDROCHLORIDE
• Active Ingredient Strength: 100 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 59572-720-12

120 CAPSULE in 1 BOTTLE, PLASTIC (59572-720-12)

• Marketing Start Date: 2019-08-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 59572-720-12 [59572072012]

Inrebic CAPSULE

• Marketing Category: NDA
• Application Number: NDA212327
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-08-16

Drug Details

Active Ingredients

Ingredient	Strength
FEDRATINIB HYDROCHLORIDE	100 mg/1